Treatment of Older Adults With Acute Lymphoblastic Leukemia.

Trial Profile

Treatment of Older Adults With Acute Lymphoblastic Leukemia.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Clofarabine (Primary) ; Cytarabine (Primary) ; Doxorubicin (Primary) ; Imatinib (Primary) ; Mercaptopurine (Primary) ; Methotrexate (Primary) ; Pegaspargase (Primary) ; Prednisone (Primary) ; Vincristine (Primary)
  • Indications Acute lymphoblastic leukaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 12 May 2016 Status changed from active, no longer recruiting to completed, as per results published in the Cancer.
    • 12 May 2016 Primary endpoint has been met. (Overall survival (OS) at 1 year), as per results published in the Cancer.
    • 12 May 2016 Results published in the Cancer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top